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Abstract
Epidemiological studies have associated environmental exposure to polychlorinated biphe-
nyls (PCBs) with an increased risk of type 2 diabetes; however, little is known about the
underlying mechanisms involved in the metabolic side-effects of PCB. Our study evaluated
the transcriptional effects of a subchronic exposure (gavage at Day 0 and Day 15 with 10 or
100 μmol/Kg bw) to PCB118 (dioxin-like PCB), PCB153 (non-dioxin-like PCB), or an equi-
molar mixture of PCB118 and PCB153 on various tissues (liver, visceral adipose tissue,
muscle, and colon) in mice. Our results showed that a short-term exposure to PCB118 and/
or PCB153 enhanced circulating triglyceride levels but did not affect glycemia. Among the
studied tissues, we did not observe any modification of the expression of inflammation-
related genes, such as cytokines or chemokines. The main transcriptional effects were
observed in visceral adipose and liver tissues. We found a downregulation of lipin1 and
glut4 expression in these two target organs. In adipose tissue, we also showed a downregu-
lation of Agpat2, Slc25a1, and Fasn. All of these genes are involved in lipid metabolism and
insulin resistance. In muscles, we observed an induction of CnR1 and Foxo3 expression,
which may be partly involved in PCB metabolic effects. In summary, our results suggest
that lipin1 and glut4, notably in adipose tissue, are the main targeted genes in PCB-induced
metabolic disorders, however, further studies are required to fully elucidate the mechanisms
involved.
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Introduction
Polychlorinated biphenyls (PCBs) are a type of organochlorine and are persistent organic pol-
lutants (POPs). PCBs are very stable and resistant to temperature and pressure extremes; in
addition, these compounds are fat-soluble, which leads to bioaccumulation in individuals and
the food chain.
PCBs have been widely used for industrial purpose over the 50 years, they were banned
since 1979 in the U.S. and other developed countries. There are 209 possible PCB congeners
that are categorized based on structural properties, such as the number of chlorine atoms in the
compound. A common classification divides PCBs into dioxin-like (which are agonists of the
Ah receptor (AhR)) and non-dioxin-like (which are agonists of constitutive androstane recep-
tor (CAR) or pregnane X receptor (PXR)) based on their structural and toxicological similarity
with the dioxin molecule.
Human exposure occurs mainly from consumption of PCB-containing foods and inhalation
of contaminated air. Fish (especially when taken from lakes or rivers with high levels of PCBs),
meat and dairy products are the main dietary sources of PCBs.
Human exposure to PCBs is associated with cancers, including non-Hodgkin lymphoma;
furthermore, PCBs have been classified as probable carcinogens to humans [1]. PCB bioaccu-
mulation can lead to reduced infection fighting ability, increased rates of autoimmunity, cogni-
tive and behavioral problems, and hypothyroidism [2]. Some research also links PCBs to
increased rates of type 2 diabetes from decreased insulin sensitivity in peripheral tissues. The
relationship of PCBs with diabetes has been investigated in several cross-sectional studies and
longitudinal studies. The evidence from cross-sectional studies supports an association of
dioxin-like PCBs with diabetes (diagnosed plus undiagnosed diabetes). The association of non-
dioxin-like PCBs and diabetes has been reported; however, this association was not significant
when PCBs were examined with other POPs. Few longitudinal studies of PCBs and diabetes
have been completed. One study concluded that only women show an association between
PCBs and diabetes; however, three studies found no association for elevated PCBs and diabetes
(for review see [3]). Despite the extensive research about relationships between PCB exposure
and diabetes, the underlying mechanism is not well understood. One potential mechanism
involves the regulation and metabolism of glucose and insulin. Olsen et al. showed that TCDD,
PCB77, and PCB52 reduced functional Glut4 (glucose transporter protein) in preadipocyte
cells lines through AhR binding [4]. Ruzzin et al. [5] studied the development of insulin resis-
tance in adult male rats exposed to crude salmon oil containing persistent organic pollutants.
These authors proposed that POPs affect nuclear receptors (AhR, CAR, and pregnane X recep-
tor), which increase chronic low grade inflammation, decrease mitochondrial function and
fatty acid oxidation, and increase lipogenesis to ultimately produce insulin resistance syn-
drome. In rat liver studies, TCDD affected the mRNA expression of numerous genes related to
glucose and insulin sensitivity, including decreases in glucokinase and fructose-6-phosphatase
transport protein 1 [6]. Other studies have focused on the peroxisome proliferator-activated
receptor (PPAR) and AhR. PPAR plays a role in glucose homeostasis and the translation of
Glut4. Dioxins, such as TCDD, bind to the AhR and antagonize PPAR and its associated func-
tions; thus, the alteration of this pathway may be another explanation for the link between
PCBs and diabetes [7]. Further studies are needed to fully elucidate the underlying genetic and
biochemical processes involved in PCB-induced type 2 diabetes.
Our study evaluated the genomic effects of a subchronic exposure to PCB118 (dioxin-like
PCB), PCB153 (non-dioxin-like PCB), or an equimolar mixture of PCB118 and PCB153 in var-
ious mouse tissues (liver, visceral adipose tissue, muscle, and colon). We have chosen these two
PCBs because humans are mainly exposed to PCBs through the consumption of PCB-
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containing fishes, and PCB118 and PCB153 are frequently found in wild fishes [8]. Among the
studied tissue, liver, visceral adipose tissue, and muscle are well defined target tissues for type 2
diabetes. But, colon is of interest, since glucagon-like peptide 1 (GLP-1) is a gut-derived hor-
mone that enhances glucose-induced insulin secretion. In addition to its pancreatic effects,
GLP-1 can induce metabolic actions by interacting with its receptors expressed on nerve cells
in the gut and the brain [9].
Materials and Methods
Chemicals
PCB118 and PCB153 were purchased from AccuStandard Inc. (New Haven, USA).
Animal treatments and sample collection
All experiments were approved by the Animal Protection Committee of the Mediterranean
University (approval N°20120102). Male C57BL/6 mice (2 months of age; Charles River Labo-
ratories, Les Oncins, France) were housed in a pathogen-free environment and given access to
food (Diet for maintenance A04, from “Safe”, Augy, France) and water ad libitum. Daily, mice
were observed in order to detect any suffering.
To minimize the contamination from pesticide residues, PCBs were dissolved in olive oil
produced from organic farming. Treatments were administered by gavage at Day 0 and Day
15.
Mice were randomly divided into 7 groups of 10 animals and given the following treat-
ments: control (olive oil), PCB118 10 μmol/Kg bw, PCB118 100 μmol/Kg bw, PCB153
10 μmol/Kg bw, PCB153 100 μmol/Kg bw, an equimolar mixture of PCB118 and PCB153
10 μmol/Kg bw, or an equimolar mixture of PCB118 and PCB153 100 μmol/Kg bw. The high-
est doses of PCB studied in our study, are comparable to those of precedent published studies
performed in mice [10–11]. After treatment, no suffering of mice was observed.
At Day 29, mice were fasted. At Day 30, mice were euthanized by the intraperitoneally injec-
tion of a lethal dose of thiopental (150 mg/Kg bw), blood samples were collected retro-orbitally,
and after cervical disruption, tissues (liver, visceral adipose tissue, muscles, and colon) were
collected. After blood centrifugation, plasma was collected for biochemical analyses. The liver
and colon samples were quickly frozen in liquid nitrogen and stored at -80°C until further use.
Visceral adipose tissue and muscles were preserved in Allprotect Tissue Reagent (Qiagen,
Courtaboeuf, France) at 4°C until further use.
Biochemical analyses
Biochemical analyses were performed on a Modular PP (Roche Diagnostics, Meylan, France)
at the Clinical Laboratory of the Hospital "La Conception" (Marseille, France). We determined
the levels of glucose, total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides, phos-
pholipids, alkaline phosphatase, alanine aminotransferase (ALT), and aspartate aminotransfer-
ase (AST).
RNA extraction
Liver, muscle, and colon RNA were extracted using a Qiagen RNeasy kit (Qiagen, France). Vis-
ceral adipose tissue RNA was extracted using Qiazol reagent (Qiagen, France) and then further
purified on a column from the RNeasy kit.
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The concentration of RNA samples was assessed using a NanoDrop Lite (Fisher Scientific
France, Illkirch, France). The quality of RNA samples was confirmed using a Bioanalyzer Agi-
lent 2100 (Agilent Technologies, Courtaboeuf, France).
For gene expression microarrays and real-time RT-PCR experiments, RNA samples of 3
mice from each treatment group were randomly pooled and analyzed.
Gene expression microarray and microarray data analysis
After assessing the RNA quality, liver, muscle, colon and adipose tissue samples with a RNA
Integrity Number (RIN) greater than 7.0 were selected for further analysis (PCB, controls and
concentrations). Samples were labeled with Agilent two-color Quick Amp labeling kits using a
total RNA input ranging from 600 to 1000 ng. Labeled cRNA was analyzed using the Nanodrop
to ensure that the amplification and labeling reactions were sufficient. Labeled cRNA was
hybridized on 18 Agilent 4x44K microarrays. Samples were then scanned on an Agilent DNA
scanner. Raw data were extracted using Feature Extraction software and analyzed with Gene-
Spring. Lastly, raw data from the 3 sample pools for each tissue (liver, colon, muscle and adi-
pose tissue) were processed for statistical analysis (Student’s t-test, P< 0.05). Only changes
greater than 2-fold were taken into account for data analyses.
Real-time RT-PCR
Reverse transcription was completed using 1 μg of pooled RNA and a High capacity cDNA
reverse transcription kit as specified by the manufacturer (Applied Biosystems, France).
PCR experiments were performed using a LightCycler480 System (Roche, France) in 384
well-plates using a liquid handler automated workstation (Biomek 3000 Beckman). The PCR
was performed with 0.4 μM of each primer and EXPRESS SYBR GreenER qPCR Supermix
(Invitrogen, France). Cycling conditions including a 2 min UDG activation at 50°C, 2 min acti-
vation at 95°C followed by 40 cycles of amplification (15 s denaturation at 95°C, 1 min primer
annealing and fragment elongation at 60°C). A melt program was performed at the end of the
PCR. The raw fluorescence data were analyzed using LightCycler480 software. Target gene
mRNA expression was normalized to β-actin, and data were quantified using the 2-ΔΔCt
method. The primers used are listed in Table 1.
Statistical analysis
A statistical analysis was performed with an ANOVA followed by a Dunnett’s test using
GraphPad Prism (GraphPad Software). Values were considered significantly different at
P< 0.05. The results are presented as the means ± SD.
Results
Effect of PCB treatment on weight and biochemical parameters
Changes in body weight in the different groups are summarized in Table 2. We did not observe
any significant variation in weight among the different treatments, except a slight decrease
with the low dose of PCB118 at Day 29.
The results of the biochemical analyses are summarized in Table 3. PCB exposure did not
induce hepatic injury at the doses used. The circulating levels of alkaline phosphatase, ALT and
AST in all treated groups were similar to the control group. We did not observe any changes in
the circulating levels of glucose, cholesterol (total, HDL and LDL), and phospholipids. Triglyc-
eride levels were significantly enhanced in PCB-exposed mice, and the highest effects were
observed with low doses of PCB118 and PCB153 (1.8-fold and 1.6-fold, respectively).
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Table 1. Primers used for real-time qRT-PCR experiments.
Primer Sequence (5'-3') Primer Sequence (5'-3')
Mus_ActB_F GGAGGGGGTTGAGGTGTT Mus_Lipin1_F TCCGGAAGTTAAATTATTTTCTTTG
Mus_ActB_R GTGTGCACTTTTATTGGTCTCAA Mus_Lipin1_R TGACGGCTATAATGCCTAAGGA
Mus_CD28_F AGCTGTTTTGGGCACTGGT Mus_Lipin2_F AACAATGTAGAGTGGACCAGGAC
Mus_CD28_R GAGCCACTGTCACTAGCAAGC Mus_Lipin2_R AGGCTGCAGGGAACAGAG
Mus_Foxo3_F AGCAACATGGGCTTGAGTG Mus_Slc25a1_F GCCATGGTCAGGTCACAGT
Mus_Foxo3_R GAGACTGCTGCTGGTGTTTG Mus_Slc25a1_R GAGGCAGCTGTGGTAGGC
Mus_Serpin1_F TTCCAGGGGTGTGATTGAATA Mus_Pfkfb3_F CAGAGGACAGCTTGACAGGA
Mus_Serpin1_R CCGTATGCCACGGTTTAAATA Mus_Pfkfb3_R GAGGCCTGGGCTCAATCT
Mus_IL2_F GCTCTACAGCGGAAGCACA Mus_Enolase1_F GAGGCGCTTAGTGCTGCT
Mus_IL2_R GAGCTCCTGTAGGTCCATCAA Mus_Enolase1_R CTGCAAAGCAAGGAAAGAGG
Mus_IL6_F ACGGCCTTCCCTACTTCAC Mus_Pygb_F CGGCTGAAGCAGGAGTACTTT
Mus_IL6_R ACAGGTCTGTTGGGAGTGGT Mus_Pygb_R TTGAACCTTCGAATGATGTCC
Mus_IL1BETA_F CAAAAGATGAAGGGCTGCTT Mus_Pnliprp1_F TGCCAACAATGTGCGAGTAG
Mus_IL1BETA_R GAAGCTGGATGCTCTCATCA Mus_Pnliprp1_R CTCACAAGGATGTCAATCATCTG
Mus_Gck_F CTGGATGACAGAGCCAGGAT Mus_Pla2g1b_F CACCGGGAAATTCTGTTAGC
Mus_Gck_R GCTGGAACTCTGCCAGGAT Mus_Pla2g1b_R GGGTGAAATAAGACAGCAAGGT
Mus_Slc2a4_F TCACTGTTTGAAGATGAGTGTCC Mus_Agpat2_F TCACCTCAGGAACAATCAAGG
Mus_Slc2a4_R GGGTGAGTGAGGCATTTTCT Mus_Agpat2_R TCTGTCAGACCATTGGTAGGG
Mus_Cyp1a1_F TCTTTTGGGAGGAAGTGGAA Mus_Lipc_F CAAGGCGTGGGAACAGAG
Mus_Cyp1a1_R TCCATACATGGAAGGCATGA Mus_Lipc_R TGGCTTCTTTAATGGCTTGC
Mus_Cyp1a2_F CTGGCTTTGACACAGTCACC Mus_Fasn_F GTGGGAGGACAGAGATGAGG
Mus_Cyp1a2_R GGCCATGTCACAAGTAGCAA Mus_Fasn_R GCTGGAGCACAAGGAACG
Mus_Cyp2b9_F CCCAAAGAGAGTGGTATTGGA Mus_Sult1e1_F TCCCAGAATAGTAAAAACTCACCTG
Mus_Cyp2b9_R CCAATTAGCGGGCTAAGAAGT Mus_Sult1e1_R TGCAATTCTTTTCCCAAAATG
Mus_Cyp2c54_F TTTATCAAGAGTTTATGGTCCTGTGTA Mus_Ifng_F GCAAAAGGATGGTGACATGA
Mus_Cyp2c54_R CATATCCATGCAACACCACAG Mus_Ifng_R TTCAAGACTTCAAAGAGTCTGAGGTA
Mus_Cyp2c70_F CCACAGTGAAATATGGGCTTTT Mus_Itgb6_F CCTGGCCTTGAACTCACAAC
Mus_Cyp2c70_R CTGAATTTTAGCTGTGACTTCTGG Mus_Itgb6_R CTCTGAGCATGAAATGGAAGG
Mus_Gpx3_F ACAATTGTCCCAGTGTGTGC Mus_Tank_F GACATAGTCTGCGAAGGAACG
Mus_Gpx3_R ACCATCCCTGGGTTTCAAG Mus_Tank_R TTGAGTTGCTCACCAATGTTTT
Mus_Gsta1_F CTTCTGACCCCTTTCCCTCT Mus_Alox5_F CACTGTTCTCTTTCGATCAACAAT
Mus_Gsta1_R GCTGCCAGGCTGTAGGAAC Mus_Alox5_R GGGGCAAAGACCTTGTCA
Mus_Gsta2_F CAAATTGAAGAAGCAAGGAAGG Mus_Mgat2_F CTGGTGTACCAGTTGAACTTCG
Mus_Gsta2_R GCCAGTATCTGTGGCTCCAT Mus_Mgat2_R CCAGGTGCCGTCATTACC
Mus_Gsto2_F CTGCTGCAGTGGAAAGTGAG Mus_Pde8b_F CGAGTCTCCAACTTTGTTTCG
Mus_Gsto2_R ACAGTCGACAGCACTCTTGC Mus_Pde8b_R TGTTTTTGTTTCTGAGGTCCTG
Mus_Pla2g1b_F CACCGGGAAATTCTGTTAGC Mus_Cnr1_F GCACCTTCACGGTTCTGG
Mus_Pla2g1b_R GGGTGAAATAAGACAGCAAGGT Mus_Cnr1_R GACTGCGGGAGTGAAGGAT
Mus_Smpd3_F AGAGCAGGGCTGACTCCA Mus_Rsg2_F ACGAAAACCCCAAGTTTCCT
Mus_Smpd3_R TGGCTCTAGTCACACGTTGG Mus_Rsg2_R GAGTAGCACAGATTATTAGCCAAATG
Mus_Gyk_F AGGCCTAGGAGAATGCAGGT
Mus_Gyk_R CCTAGGCAGCCCCTTTACTC
doi:10.1371/journal.pone.0128847.t001
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Results of microarray analyses
The expression of approximately 1,000 genes was significantly modulated by PCB exposure.
We selected genes that showed a minimum of a 2-fold (up or down) change in expression in at
least two treated groups for further analyses.
The results of gene expression changes within multiple pathways are summarized in Tables
4–7.
Table 4 highlights the selected genes involved in the metabolism of xenobiotics. The largest
effects were observed in the liver, especially in cytochrome P450s (Cyp). PCB118 enhanced
Cyp1a subfamily expression, while PCB153 induced the expression of the Cyp2b subfamily.
Interestingly, PCB118 and PCB153, alone or in combination, reduced glutathione S-transferase
(GST) expression. In adipose tissue, we observed an induction of the glutathione peroxidase 3
(Gpx3) at the lowest studied dose.
Table 5 summarizes the selected genes involved in glucose homeostasis and insulin signal-
ing. In the liver, we observed a decrease in glucokinase (Gck) expression after PCB118 or
PCB153 exposure. In muscles, the decrease in Gck was mediated by PCB118 only. In adipose
tissue, glycogen phosphorylase (Pygb) and 2,4-dienoyl CoA reductase 1 (Decr1) were downre-
gulated. In muscles, the expression of 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3
(Pfkfb3) and forkhead box O3 (Foxo3) were enhanced. In the liver and muscles, the expression
Table 2. Changes in body weight in the different groups (*p < 0.05).
Control PCB11810
μmol/kg
PCB118100
μmol/kg
PCB15310
μmol/kg
PCB153100
μmol/kg
PCB Mix10
μmol/kg
PCB mix
100 μmol/kg
D0 24.10 ± 1.48 22.90 ± 0.74 23.90 ± 0.94 23.20 ± 1.20 22.90 ± 0.92 24.00 ± 1.00 23.30 ± 1.36
D7 25.17 ± 1.67 23.75 ± 0.83 24.86 ± 0.78 23.93 ± 1.22 23.91 ± 1.15 25.08 ± 1.09 24.12 ± 1.12
D15 26.35 ± 1.81 24.62 ± 0.89 25.96 ± 0.66 24.99 ± 1.35 24.97 ± 1.03 26.26 ± 1.17 25.21 ± 1.31
D21 26.83 ± 1.73 25.41 ± 1.01 26.69 ± 0.93 25.62 ± 1.23 25.77 ± 1.09 26.97 ± 1.05 25.84 ± 1.07
D29 28.27 ± 1.48 25.43 ± 0.76* 27.40 ± 0.67 26.25 ± 1.72 26.83 ± 1.27 27.88 ± 0.54 25.64 ± 1.11
D0: start of the treatment. D7: 8th day of treatment. D15: 16th day of treatment. D21: 22h day of treatment. D29: 30th day of treatment.
doi:10.1371/journal.pone.0128847.t002
Table 3. Biochemical parameters from the different groups (*p < 0.05).
Control PCB118
10 μmol/kg
PCB118
100 μmol/kg
PCB153
10 μmol/kg
PCB153
100 μmol/kg
PCB mix
10 μmol/kg
PCB mix
100 μmol/kg
Glucose (mmol/L) 8.6 ± 2.3 7.6 ± 1.3 7.1 ± 0.8 7.3 ± 1.0 6.6 ± 0.6 6.6 ± 0.6 6.5 ± 1.0
Total Cholesterol
(mmol/L)
2.1 ± 0.1 2.2 ± 0.1 2.1 ± 0.1 2.2 ± 0.2 1.9 ± 0.2 2.2 ± 0.1 2.1 ± 0.4
HDL Cholesterol
(mmol/L)
2.0 ± 0.1 2.0 ± 0.1 1.9 ± 0.1 1.9 ± 0.3 1.8 ± 0.2 2.0 ± 0.2 1.9 ± 0.3
LDL Cholesterol
(mmol/L)
0.2 ± 0.0 0.1 ± 0.0 0.1 ± 0.0 0.1 ± 0.1 0.1 ± 0.0 0.2 ± 0.3 0.2 ± 0.0
Triglycerides (mmol/L) 0.5 ± 0.1 0.9 ± 0.1* 0.7 ± 0.1* 0.8 ± 0.2* 0.5 ± 0.1 0.6 ± 0.1 0.6 ± 0.1
Phospholipids
(mmol/L)
2.1 ± 0.1 2.4 ± 0.2 2.3 ± 0.1 2.4 ± 0.2 2.0 ± 0.3 2.4 ± 0.2 2.2 ± 0.2
Alkaline Phosphatases
(UI/L)
66.6 ± 9.3 75.8 ± 5.6 69.5 ± 10.3 73.9 ± 13.0 75.9 ± 8.0 73.4 ± 4.5 67.4 ± 18.8
A.S.T. (UI/L) 47.7 ± 9.2 40.9 ± 4.0 57.6 ± 25.3 45.8 ± 12.2 55.6 ± 11.0 48.9 ± 11.8 48.7 ± 12.2
A.L.T. (UI/L) 16.1 ± 2.7 15.3 ± 2.8 18.8 ± 6.2 15.3 ± 4.0 15.0 ± 3.5 14.3 ± 2.8 16.0 ± 6.0
doi:10.1371/journal.pone.0128847.t003
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of cannabinoid receptor 1 (Cnr1) was induced. This effect was more pronounced at the lowest
studied dose.
Table 6 summarizes the selected genes involved in lipid homeostasis. In the liver, pancreatic
lipase related protein 1 (Pnliprp1) and monoacylglycerol O-acyltransferase 2 (Mogat 2) were
induced by PCB118 and/or PCB153 exposure, whereas lipin 1 (Lpin 1) expression was downre-
gulated. In adipose tissue, fatty acid synthase (Fasn) expression was reduced by PCB118 and/or
PCB153 exposure. In addition, PCB118 reduced the expression of glycerol-3-phosphate dehy-
drogenase 1 (Gpd1) and 1-acylglycerol-3-phosphate O-acyltransferase 2 (Agpat2). In the mus-
cles, lipin 2 (Lpin2) and regulator of G-protein signaling 2 (Rgs2) expression was increased,
and the expression of phospholipase A2, group IB (Pla2g1b) was decreased.
Table 7 shows the results obtained for genes involved in inflammation and the immune sys-
tem. In the liver, we observed an induction of sphingomyelin phosphodiesterase 3 (Smpd3)
after exposure to PCB118 and/or PCB153. GATA binding protein 3 (Gata3) was also induced
only after exposure to PCB118 or PCB153 individually. In adipose tissue, an increase in serpine
1 expression was observed after exposure to a mixture of PCB118 and PCB153.
Real-time RT-PCR results
The results obtained in the liver, visceral adipose tissue, muscles, and colon are summarized in
Tables 8–11, respectively.
Table 4. Genes involved in the metabolism of xenobiotics based onmicroarray analyses.
LIVER
Gene PCB118-10 PCB118-100 PCB153-10 PCB153-100 PCB MIX-10 PCB MIX-100
Cyp1a1 211 59.7
Cyp1a2 4.8 3.9
Cyp2b9 12.6 9.4 30.6 2.5 26.3
Cyp2b10 14.0 9.5 33.9 2.6 28.7
Cyp2c54 2.5 2.0
Cyp2c70 -2.7 -2.2 -2.4 -2.5 -2.9
Fmo3 -2.3 -2.2 -3.4
Gsta1 -2.3 -2.0 -2.3
Gsta2 -2.1 -2.3
Gsto2 -2.0 -2.1
Sult1e1 3.3 4.7
VISCERAL ADIPOSE TISSUE
Gene PCB118-10 PCB118-100 PCB153-10 PCB153-100 PCB MIX-10 PCB MIX-100
Cyp1a1 5.7
Cyp11a1 2.5
Fmo3 3.0
Gpx3 2.7 2.3 2.9
MUSCLES
Gene PCB118-10 PCB118-100 PCB153-10 PCB153-100 PCB MIX-10 PCB MIX-100
Cyp1a1 15.8 2.6
Gsta2 -2.1
Gsto2 -3.1
COLON
Cyp1a1 2.9
Cyp11a1 2.6 2.4 2.6 3.2 2.5 2.3
doi:10.1371/journal.pone.0128847.t004
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For genes involved in the metabolism of xenobiotics, our results confirmed the hepatic
induction of Cyp1a2, Cyp2b9, Cyp2c54 and the repression of Cyp2c70. No significant modifi-
cation was observed in the hepatic expression of Cyp1a1; however, this isoform is mainly
expressed in extrahepatic tissues. In the colon, Cyp1a1 and Cyp2c70 expression was slightly
increased. We confirmed the downregulation of Gsta1, Gsta2, and Gsto2 expression in the
liver. Surprisingly, we observed an increase in Gsta2 expression in muscles. Moreover, PCB153
alone or in combination with PCB118 enhanced Sult1e1 expression.
Table 5. Genes involved in glucose homeostasis and insulin signaling based onmicroarray analyses.
LIVER
Gene PCB118-10 PCB118-100 PCB153-10 PCB153-100 PCB MIX-10 PCB MIX-100
Gck -4.1 -4.3 -3.2 -3.0
CnR1 2.9 2.7
VISCERAL ADIPOSE TISSUE
Gene PCB118-10 PCB118-100 PCB153-10 PCB153-100 PCB MIX-10 PCB MIX-100
Pygb -2.8 -2.2 -2.4 -2.6 -4.9
Decr1 -2.1 -2.4 -2.0 -2.2 -2.0
Foxo3 4.9
MUSCLES
Gene PCB118-10 PCB118-100 PCB153-10 PCB153-100 PCB MIX-10 PCB MIX-100
Gck -2.5 -2.2 -2 -2
Foxo3 2.4 3.5 2.4 2.5
Pfkfb3 2.6 2.9 2.1 2.8
CnR1 2.2 3.2 3.2 2.9
doi:10.1371/journal.pone.0128847.t005
Table 6. Genes involved in lipid homeostasis based onmicroarray analyses.
LIVER
Gene PCB118-10 PCB118-100 PCB153-10 PCB153-100 PCB MIX-10 PCB MIX-100
Lpin 1 -3.0 -2.4 -2.0 -2.1
Pnliprp1 2.9 3.9 4.5
Mogat2 2.3 5.1 3.1 2.4 4.1
Alox5 2.2 2.5 2.4
Pde8b 2.9 2.8
VISCERAL ADIPOSE TISSUE
Gene PCB118-10 PCB118-100 PCB153-10 PCB153-100 PCB MIX-10 PCB MIX-100
Fasn -6.5 -6.6 -5.2 -5.7 -6.8
Agpat2 -2.1 -2.0
Gpd1 -2.7 -2.6
Pla2g1b -4.0
Pde8b 3.2 5.6
MUSCLES
Gene PCB118-10 PCB118-100 PCB153-10 PCB153-100 PCB MIX-10 PCB MIX-100
Lipc -2.3 -2.8 2.6
Pla2g1b -2.8 -4.1 -3.4
Lpin 2 2.5 2.8 3.0 2.5 2.5
Rgs2 2.6 2.5 2.5 2.1
Pde8b 2.6
doi:10.1371/journal.pone.0128847.t006
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Within the changes in gene expression for glucose homeostasis and insulin signaling, the
data for Gck are conflicting. The microarray analysis showed a decrease in Gck expression in
the liver and muscles. However, qRT-PCR analysis showed only a slight variation in the liver
and an increase in the muscle. For CnR1, our data confirmed the induction of its expression in
muscles, and PCB153 exerted a stronger effect when compared with PCB118. CnR1 hepatic
expression was reduced, except after exposure to the mixture of PCBs. We confirmed the
decrease in Foxo3 and Pfkfb3 in the muscles. Moreover, we used qRT-PCR to verify changes in
Glut4 expression because previous studied showed its decrease in 3T3 L1 after TCDD exposure
[4]. After PCB exposure, Glut4 expression showed minor changes in the liver, muscle and
colon; however, Glut4 was clearly downregulated in adipose tissue. Pygb was downregulated in
this tissue to a lesser extent than previously observed using microarray analyses.
For genes involved in lipid homeostasis, qRT-PCR analysis confirmed a decrease in lpin 1
expression in liver and adipose tissue and an increase in muscular lpin2 expression. Agpat2
expression was decreased in adipose tissue after exposure to PCB. The induction of Rsg2 and a
Table 7. Genes involved in inflammation and the immune system based onmicroarray analyses.
LIVER
Gene PCB118-10 PCB118-100 PCB153-10 PCB153-100 PCB MIX-10 PCB MIX-100
Gata 3 3.8 4.1 2.4 3.1
PU1 -2.5 -2.1
CD28 -2.0 -2.0
IL1β 2.3
IL5 -2.5 -3.4
Ifng 2.3 -2.8
Smpd3 2.3 3.8 2.7
VISCERAL ADIPOSE TISSUE
Gene PCB118-10 PCB118-100 PCB153-10 PCB153-100 PCB MIX-10 PCB MIX-100
Serpine 1 2.7 2.8
Slc25a1 -3.7 -3.1 -2.9 -2.7 -3.8
Tank 3.6
Gata 3 -18.1
Srgn 3.2 2.7 4.7 2.4
Elk4 2.8 4.7
CD28 -2.0
IL5 -2.9
MUSCLES
Gene PCB118-10 PCB118-100 PCB153-10 PCB153-100 PCB MIX-10 PCB MIX-100
Serpine 1 2.1
Tank 11.1 7.8 11.7 7.8 12.2 6.6
PU1 -3.9 -4.8 -3.2
Elk4 3.5 2.9
IL1β -2.0
IL2 -2.1 -2.2 -2.5 -3.7
IL5 -2.5 -2.7
IL6 2.9 2.6
Ifng -2.4 -3.5
COLON
Tank 4.1 4.0 5.2 7.9 3.7 4.9
PU1 -2.7 -2.2
doi:10.1371/journal.pone.0128847.t007
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decrease in Pla2g1b in the muscles was confirmed. Fasn expression was decreased in adipose
tissue after exposure to PCB153; however, exposure to PCB118 alone or in combination caused
an increase in Fasn expression. For Gyk, the qRT-PCR analysis did not confirm an increase in
its expression in muscles after exposure to a mixture of PCB118 and PCB153. Exposure to
Table 8. Real-time RT-PCR validation of genes selected within the liver after microarray analyses (*p < 0.05).
C PCB118-10 PCB118-100 PCB153-10 PCB153-100 PCB MIX-10 PCB MIX-100
Alox5 1.0 ± 0.3 0.5 ± 0.1* 0.4 ± 0.1* 0.4 ± 0.1* 0.3 ± 0.0* 0.5 ± 0.2* 0.5 ± 0.1*
CD28 1.0 ± 0.2 0.7 ± 0.4 1.0 ± 0.0 0.8 ± 0.1 0.7 ± 0.1 1.2 ± 0.2 1.8 ± 0.2*
Cnr1 1.0 ± 0.1 0.4 ± 0.1* 0.8 ± 0.2 0.7 ± 0.1* 0.3 ± 0.0* 1.0 ± 0.0 1.2 ± 0.3
Cyp1a1 1.0 ± 0.2 0.9 ± 0.1 0.7 ± 0.1 0.6 ± 0.0* 0.3 ± 0.1* 0.8 ± 0.0 1.1 ± 0.1
Cyp1a2 1.0 ± 0.1 11.0 ± 3.6* 5.9 ± 1.6* 2.6 ± 0.3* 2.6 ± 0.5* 3.3 ± 0.6* 0.8 ± 0.5
Cyp2b9 1.0 ± 0.1 2.7 ± 0.0* 1.1 ± 0.1 12.3 ± 3.2* 1.8 ± 0.4* 11.0 ± 1.3* 1.4 ± 0.4
Cyp2c54 1.0 ± 0.2 2.0 ± 0.4* 2.0 ± 0.1* 2.6 ± 0.3* 1.3 ± 0.1 1.9 ± 0.3* 1.0 ± 0.5
Cyp2c70 1.0 ± 0.3 0.3 ± 0.0* 0.4 ± 0.1* 0.4 ± 0.0* 0.4 ± 0.1* 0.5 ± 0.2* 0.4 ± 0.1*
Gck 1.0 ± 0.2 0.8 ± 0.3 0.9 ± 0.2 0.9 ± 0.2 0.7 ± 0.0* 1.9 ± 0.7 1.1 ± 0.3
Glut 4 1.0 ± 0.1 0.8 ± 0.1* 1.0 ± 0.1 0.8 ± 0.1* 0.6 ± 0.1* 1.6 ± 0.1* 1.3 ± 0.1*
Gsta1 1.0 ± 0.1 0.6 ± 0.0* 0.5 ± 0.1* 0.5 ± 0.1* 0.4 ± 0.0* 0.6 ± 0.1* 0.6 ± 0.2*
Gsta2 1.0 ± 0.0 0.4 ± 0.1 0.3 ± 0.0 0.4 ± 0.1 0.3 ± 0.1 0.7 ± 0.1 0.5 ± 0.1
Gsto2 1.0 ± 0.1 1.0 ± 0.5 0.5 ± 0.3* 0.4 ± 0.0* 0.6 ± 0.2* 0.4 ± 0.2* 0.3 ± 0.1*
IL-1B 1.0 ± 0.0 1.2 ± 0.1 1.7 ± 0.0* 1.0 ± 0.1 0.9 ± 0.0 2.5 ± 0.9* 1.7 ± 0.1*
Infg 1.0 ± 0.5 0.3 ± 0.1* 0.9 ± 0.1 0.8 ± 0.3 1.1 ± 0.2 1.0 ± 0.3 0.7 ± 0.3
Lipc 1.0 ± 0.2 0.8 ± 0.2 1.7 ± 0.4* 0.8 ± 0.2 0.9 ± 0.2 0.9 ± 0.1 1.1 ± 0.5
Lpin 1 1.0 ± 0.1 0.3 ± 0.1* 0.3 ± 0.0* 0.3 ± 0.1* 0.4 ± 0.1* 0.4 ± 0.1* 0.6 ± 0.0*
Mogat2 1.0 ± 0.1 0.9 ± 0.2 1.4 ± 0.1* 0.8 ± 0.1 1.0 ± 0.2 0.7 ± 0.1 1.1 ± 0.2
Pde8b 1.0 ± 0.1 0.9 ± 0.2 0.9 ± 0.2 1.1 ± 0.2 0.8 ± 0.1 0.9 ± 0.1 0.9 ± 0.2
Pnliprp1 1.0 ± 0.3 0.5 ± 0.2* 0.9 ± 0.2 0.7 ± 0.0* 0.6 ± 0.2* 1.2 ± 0.5 1.3 ± 0.3
Smpd3 1.0 ± 0.1 0.6 ± 0.1* 0.6 ± 0.0* 1.1 ± 0.2 0.6 ± 0.1* 1.1 ± 0.2 0.8 ± 0.1
Sult1e1 1.0 ± 0.3 0.9 ± 0.0 0.8 ± 0.1 2.8 ± 0.3* 3.0 ± 1.9* 2.6 ± 0.5* 1.1 ± 0.3
doi:10.1371/journal.pone.0128847.t008
Table 9. Real-time RT-PCR validation of genes selected within the visceral adipose tissue after microarray analyses (*p < 0.05).
C PCB118-10 PCB118-100 PCB153-10 PCB153-100 PCB MIX-10 PCB MIX-100
Agpat2 1.0 ± 0.1 0.6 ± 0.0* 0.4 ± 0.1* 0.5 ± 0.2* 0.5 ± 0.0* 0.5 ± 0.1* 0.3 ± 0.1*
CD28 1.0 ± 0.0 0.7 ± 0.4 0.5 ± 0.1* 0.4 ± 0.1* 0.5 ± 0.2* 2.2 ± 0.3* 1.3 ± 0.1
Cyp1a1 1.0 ± 0.5 0.7 ± 0.2 1.0 ± 0.7 0.8 ± 0.1 0.8 ± 0.2 1.4 ± 0.2 0.9 ± 0.2
Eno1 1.0 ± 0.5 0.4 ± 0.1* 0.3 ± 0.0* 0.4 ± 0.1* 0.3 ± 0.0* 0.6 ± 0.1* 0.5 ± 0.0*
Fasn 1.0 ± 0.1 3.7 ± 4.1 1.8 ± 1.0* 0.4 ± 0.1* 0.4 ± 0.2* 2.6 ± 0.6* 1.5 ± 0.3*
Foxo3 1.0 ± 0.4 0.8 ± 0.2 0.7 ± 0.0 0.8 ± 0.1 0.7 ± 0.2 0.9 ± 0.2 0.8 ± 0.3
Glut4 1.0 ± 0.3 0.5 ± 0.0* 0.6 ± 0.1* 0.5 ± 0.2* 0.5 ± 0.2* 1.1 ± 0.1 0.7 ± 0.2
Gpx3 1.0 ± 0.1 0.8 ± 0.1 2.2 ± 0.6* 1.2 ± 0.4 1.7 ± 0.8 1.2 ± 0.2 3.8 ± 1.2*
IL-1B 1.0 ± 0.2 0.3 ± 0.0* 0.3 ± 0.1* 0.2 ± 0.1* 0.2 ± 0.1* 1.7 ± 0.8 0.9 ± 0.1
Lpin1 1.0 ± 0.1 0.7 ± 0.1* 0.4 ± 0.0* 1.2 ± 0.5 0.7 ± 0.4 1.3 ± 0.4 0.9 ± 0.2
Pde8b 1.0 ± 0.1 0.9 ± 0.0 0.8 ± 0.1 0.8 ± 0.0 0.7 ± 0.2 1.8 ± 0.4* 1.0 ± 0.2
Pla2g1b 1.0 ± 0.3 1.6 ± 0.4 1.1 ± 0.3 1.1 ± 0.4 1.1 ± 0.4 3.8 ± 1.0* 1.9 ± 0.3
Pygb 1.0 ± 0.1 1.0 ± 0.4 0.8 ± 0.0* 0.9 ± 0.1 0.9 ± 0.3 0.7 ± 0.1* 0.8 ± 0.4
Serpine 1 1.0 ± 0.1 0.7 ± 0.1* 0.9 ± 0.4 1.4 ± 0.1* 0.7 ± 0.3 1.5 ± 0.4 2.0 ± 1.0
Slc25a1 1.0 ± 0.2 0.4 ± 0.0* 0.5 ± 0.2* 0.4 ± 0.1* 0.4 ± 0.1* 0.7 ± 0.2 0.5 ± 0.0*
Tank 1.0 ± 0.1 0.6 ± 0.0* 0.8 ± 0.1 0.9 ± 0.2 0.7 ± 0.2 0.8 ± 0.2 0.7 ± 0.3
doi:10.1371/journal.pone.0128847.t009
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PCB118 produced a decrease in Gyk expression. Similarly, there were some discrepancies with
the results obtained for Alox5, Mogat2, Pnliprp1 and Pde8b. qRT-PCR analysis showed a
marked decrease in Alox5 hepatic expression after PCB118 or PCB153 exposure; however, the
microarray data showed an induction of Alox5. For Mogat2, the microarray data showed an
increase in hepatic expression; however, we observed only minor changes in expression using
qRT-PCR.
Analysis of microarray or qRT-PCR results did not show significant changes in genes
involved in inflammation or the immune system, such as pro-inflammatory cytokines and che-
mokines. A mild increase in serpine 1 was found in adipose tissue after exposure to the mixture
of PCB118 and PCB153. Minor changes in hepatic Smpd3 were not confirmed. Tank expres-
sion in the colon remained stable, and data obtained from muscles suggest that Tank is poorly
expressed (Cp 35 cycles).
Discussion
Except for a significant increase in triglyceridemia after exposure to PCB118 and/or PCB153,
we did not observe any changes in the other selected biochemical parameters. The greatest
Table 10. Real-time RT-PCR validation of genes selected within the muscles after microarray analyses (*p < 0.05).
C PCB118-10 PCB118-100 PCB153-10 PCB153-100 PCB MIX-10 PCB MIX-100
CD28 1.0 ± 0.9 1.6 ± 2.6 0.9 ± 1.1 0.2 ± 0.0 0.4 ± 0.1 0.4 ± 0.1 0.0 ± 0.0
Cnr1 1.0 ± 0.2 1.3 ± 0.1 1.5 ± 0.0* 3.8 ± 1.8* 20.1 ± 13.7* 13.1 ± 2.1* 1.6 ± 0.2*
Cyp1a1 1.0 ± 0.1 1.7 ± 0.3* 1.7 ± 1.3 1.4 ± 0.5 1.6 ± 0.8 1.1 ± 0.3 1.2 ± 0.1
Foxo3 1.0 ± 0.4 1.7 ± 0.3 1.4 ± 0.2 1.1 ± 0.1 1.5 ± 0.2 1.3 ± 0.1 1.0 ± 0.2
Gck 1.0 ± 0.3 1.1 ± 0.0 3.1 ± 3.3 2.1 ± 0.9 1.9 ± 1.2 2.0 ± 1.2 1.5 ± 0.1
Glut4 1.0 ± 0.3 1.1 ± 0.3 1.2 ± 0.1 1.3 ± 0.1 1.2 ± 0.4 1.0 ± 0.2 1.2 ± 0.1
Gsta2 1.0 ± 0.1 1.0 ± 0.1 1.9 ± 0.9 3.3 ± 2.2 6.4 ± 1.7* 6.7 ± 2.5* 1.0 ± 0.2
Gyk 1.0 ± 0.8 0.6 ± 0.0 0.8 ± 0.2 1.0 ± 0.4 1.3 ± 0.6 0.8 ± 0.2 0.9 ± 0.0
Ifng 1.0 ± 0.2 2.0 ± 0.5 0.5 ± 0.6 0.1 ± 0.1 0.5 ± 0.7 0.3 ± 0.2 0.1 ± 0.1
IL-1beta 1.0 ± 0.2 1.4 ± 0.3 1.5 ± 0.0* 2.4 ± 1.1* 2.5 ± 1.3 3.5 ± 2.4 1.6 ± 0.2*
IL2 1.0 ± 0.2 2.5 ± 2.2 0.9 ± 1.1 0.2 ± 0.1* 1.2 ± 1.4 0.3 ± 0.2* ND
IL6 1.0 ± 0.8 0.1 ± 0.0* 0.9 ± 1.1 0.1 ± 0.1* 1.0 ± 1.0 0.5 ± 0.2 0.1 ± 0.0
Lipc 1.0 ± 0.3 1.3 ± 0.3 2.2 ± 1.1 1.8 ± 0.8 1.9 ± 1.2 1.4 ± 0.4 1.9 ± 0.4*
Lpin2 1.0 ± 0.0 3.7 ± 1.3* 4.3 ± 3.0* 3.3 ± 0.8* 3.3 ± 0.2* 2.7 ± 0.4* 2.5 ± 1.3*
Pde8b 1.0 ± 0.2 1.4 ± 0.2 1.2 ± 0.3 1.5 ± 0.1* 1.5 ± 0.1* 1.9 ± 0.3* 1.2 ± 0.2
Pfkfb3 1.0 ± 0.1 3.4 ± 1.4* 3.5 ± 0.8* 2.8 ± 0.4* 3.5 ± 1.2* 2.1 ± 0.7* 1.8 ± 0.5*
Pla2g1b 1.0 ± 1.3 0.0 ± 0.0* 0.1 ± 0.0* 0.3 ± 0.4* 0.9 ± 0.8 0.7 ± 0.1 0.0 ± 0.0*
Rgs2 1.0 ± 0.1 1.5 ± 0.1* 2.0 ± 0.2* 3.7 ± 1.2* 18.4 ± 7.2* 11.0 ± 5.9* 1.6 ± 0.2*
Serpine 1 1.0 ± 1.1 0.2 ± 0.0* 0.3 ± 0.2* 0.2 ± 0.1* 0.3 ± 0.1* 0.5 ± 0.1* 0.3 ± 0.1*
doi:10.1371/journal.pone.0128847.t010
Table 11. Real-time RT-PCR validation of genes selected within the colon after microarray analyses (*p < 0.05).
C PCB118-10 PCB118-100 PCB153-10 PCB153-100 PCB MIX-10 PCB MIX-100
Cyp1a1 1.0 ± 0.1 1.4 ± 0.2* 1.7 ± 0.6 1.4 ± 0.4 2.6 ± 0.6* 1.3 ± 0.2 1.5 ± 0.3
Cyp2c70 1.0 ± 0.2 1.8 ± 0.3* 0.5 ± 0.0* 1.9 ± 0.4* 1.2 ± 0.2 1.4 ± 0.9 1.4 ± 0.2
Glut4 1.0 ± 0.2 0.7 ± 0.1 0.9 ± 0.3 0.8 ± 0.2 0.9 ± 0.2 0.9 ± 0.2 0.9 ± 0.1
IL-1B 1.0 ± 0.2 0.5 ± 0.1* 0.5 ± 0.0* 0.8 ± 0.3 0.8 ± 0.1 0.7 ± 0.2 0.9 ± 0.2
Serpine 1 1.0 ± 0.3 1.4 ± 0.0* 0.5 ± 0.2 1.5 ± 0.3 1.3 ± 0.4 1.6 ± 0.9 1.6 ± 0.7
Tank 1.0 ± 0.1 1.0 ± 0.3 0.4 ± 0.1* 1.2 ± 0.1 1.4 ± 0.1* 1.0 ± 0.2 1.2 ± 0.2
doi:10.1371/journal.pone.0128847.t011
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induction of triglyceridemia was found in groups exposed to the lowest doses of PCB118 or
PCB153. Hypertriglyceridemia observed after PCB exposure could be explained by insulin
resistance. Unfortunatly, we did not get enough material to determine insulinemia, and we can-
not calculate HOMA-IR in order to evaluate peripheral insulin resistance.
For genes related to xenobiotic metabolism, we observed an induction of Cyp1a2 in the liver
and Cyp1a1 in the colon after exposure to PCB118. The induction of the Cyp1 family by
PCB-DL has been previously described. Our data demonstrated that non-DL PCBs, such as
PCB153, can also induce Cyp1a expression, albeit to a lesser extent. Interestingly, the increase
in Cyp1a expression was associated with a decrease in Gst expression. Cyp1a catalyzes the
bioactivation of various environmental procancerogens (such as PAHs and arylamines present
in our diet) into electrophilic metabolites [12]. Typically, these reactive metabolites are further
detoxified by Gst [13]. Therefore, our data suggest that PCB exposure increases bioactivation
reactions while reducing the detoxification process, which leads to an increased susceptibility
to procarcinogens. This phenomenon could explain the carcinogenic effects of PCB. Moreover,
electrophile metabolites can induce inflammatory responses [14], and the resulting hepatic
inflammation could be partly responsible for the metabolic side effects of PCB. The hepatic
induction of Cyp2b expression after PCB153 exposure has been previously described in rats
[15]. The human ortholog CYP2B6 is involved in the hepatic degradation of certain drugs [16],
and exposure to non-DL PCBs could modify the pharmacokinetic of such drugs. In the liver,
we observed an induction of estrogen sulfotransferase (Sult1e1) after exposure to PCB153
either alone or in combination with PCB118. Sult1e1 expression is regulated by CAR in mice
[17], and it was recently suggested that Sult1e1 functions as a negative regulator of adipogenesis
[18].
For genes involved in glucose homeostasis, insulin signaling, lipid homeostasis and inflam-
mation, we have focused on CnR1, lipin 1 and 2, Glut4, Agpat2, Slc25a1, Fasn and Foxo 3.
Recent studies have shown that the endocannabinoid system has significant effects on
energy balance and metabolism through the central control of appetite and peripheral metabo-
lism [19]. PCB exposure slightly modified the hepatic expression of CnR1; however, PCB153
alone or with PCB118 induced a potent increase in CnR1 expression in muscles. Interestingly,
in humans, CnR1 participates in the negative crosstalk between fat and keletal muscle cells,
and recent data suggest it may play a role in the development of insulin resistance [20]. There-
fore, CnR1 may be partly involved in some of metabolic side effects of PCB.
Our results showed that exposure to PCB118 and/or PCB153 reduced the expression of
Lipin 1 in the liver and, to a lesser extent, in adipose tissue. Studies of lipin 1–deficient mice
and cells have shown that lipin 1 is required for adipocyte differentiation. Lipin 1–deficient
cells and tissues failed to induce expression of two key transcription factors of adipocyte differ-
entiation, PPARγ and C/EBPα. Instead, these cells expressed high levels of preadipocyte factor-
1, an inhibitor of adipogenesis [21]. A strong negative correlation between lipin 1 mRNA levels
in adipose tissue and glucose levels, insulin levels, and insulin resistance has been described in
mice and humans [22]. In humans, adipose Lipin 1 gene expression was strongly associated
with both basal and insulin-mediated subcutaneous adipocyte glucose transport and mRNA
levels of Glut4 [23]. Interestingly, we also observed a decrease in Glut4 expression in adipose
tissue after exposure to PCB118 and/or PCB153. In addition, we showed a less pronounced
downregulation of Glut4 expression in other tissues. The insulin-regulated glucose transporter
Glut4 is mainly expressed in insulin-responsive tissues, i.e., white and brown adipose tissue
and heart and skeletal muscles. Glut4 mediates glucose uptake in response to acute insulin
stimulation [24]. Insulin-regulated glucose uptake in skeletal muscle and adipose tissue is
dependent on the redistribution of Glut4 from intracellular storage sites to the plasma mem-
brane [25]. Impaired insulin stimulation of glucose uptake in adipose tissue and skeletal muscle
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is one of the earliest defects detected in insulin-resistant states. Insulin-resistance in type 2 dia-
betes, obesity, and aging is associated with a marked reduction in the intracellular pool of
Glut4 protein in adipose cells, which in turn impairs insulin stimulation of glucose transport
[26].
Exposure to PCB118, and/or PCB153 enhanced the expression of Lipin 2 in muscles. Lipin-
2 is prominently expressed in the liver, and its hepatic expression is induced in mice by fasting
and diet-induced obesity [27]. Lipin 2 induction in the liver is associated to hepatic insulin
resistance [28]. However, little is known concerning the role of lipin 2 in muscles.
Agpat2 expression was downregulated in adipose tissue after exposure to PCB118 and/or
PCB153. AGPATs catalyze the conversion of lysophosphatidic acid to phosphatidic acid and
play a critical role in the biosynthesis of glycerophospholipids and triglycerides from glycerol-
3-phosphate [29]. A role for Agpat2 in triglyceride synthesis and adipocyte biology has
emerged since the discovery of mutations in AGPAT2 caused an autosomal recessive form of
congenital generalized lipodystrophy (CGL) type 1. Patients with CGL are born with a near
complete absence of adipose tissue and are prone to develop metabolic complications associ-
ated with insulin resistance, such as impaired glucose tolerance, diabetes, hypertriglyceridemia,
and hepatic steatosis early in life [30]. Similarly, Agpat2−/−mice develop severe lipodystrophy
affecting both white and brown adipose tissues, severe insulin resistance, diabetes, and hepatic
steatosis [31]. The results obtained in 3T3-L1 preadipocytes after knockdown or overexpres-
sion of Agpat2 suggested that Agpat2 regulates adipogenesis through the modulation of the
lipoma and by altering the normal activation of phosphatidylinositol 3-kinase (PI3K)/Akt and
PPARγ pathways in the early stages of adipogenesis [32]. Therefore, Agpat2 may be partly
involved in the metabolic side effects of PCB.
We also observed a decrease in Slc25a1 expression in adipose tissue after PCB exposure.
Slc25a1 is a member of the mitochondrial carrier subfamily of solute carrier proteins and is an
essential component of the shuttle system that transports acetyl-CoA from the mitochondria
to the cytosol for lipogenesis. Slc25a1 plays an important role in glucose-stimulated insulin
secretion [33]. Slc25a1 is regulated by SREBP-1, as well as PPARα and PPARγ in hepatocytes
and adipocytes, respectively [34]. Moreover, the activation of AhR by TCDD suppresses
PPARγ1 expression and subsequent adipocyte differentiation in C3H10T1/2 cells [35]. There-
fore, PCB-DL exposure may downregulate PPARγ in adipose tissue, leading to a decrease in
Slc25a1.
Fasn is a key enzyme required for the de novo synthesis of fatty acids. Fasn was induced in
adipose tissue after exposure to PCB118 alone or in combination with PCB153. In murine adi-
pose tissue, large adipocytes have a higher expression of Fasn and are more insulin-resistant
than small adipocytes [36]. In humans, increased FASN gene expression in adipose tissue is
linked to visceral fat accumulation, impaired insulin sensitivity, increased circulating fasting
insulin, IL-6, leptin and RBP4 [37]. Therefore, Fasn may be partly involved in the metabolic
effects of PCB.
In muscles, we observed an induction of Foxo3 expression. Foxo family member proteins
are highly conserved transcription factors with important roles in cellular homeostasis, espe-
cially skeletal muscle. Foxo1 and Foxo3 are key players in muscle energy homeostasis through
the control of glycolytic and lipolytic flux and mitochondrial metabolism. Their exacerbated
activation occurs in several diseases and results in atrophy, mitochondrial dysfunction, and a
detrimental shift in the muscle phenotype [38–39]. Therefore, Foxo3 may be partly involved in
PCB-induced metabolic diseases. However, additional studies are needed to elucidate the pre-
cise role of these proteins in mitochondrial homeostasis.
In our environment we are exposed to mixtures of PCBs, therefore we have evaluated the
effect of an exposition to an equimolar mixture of PCB118 and PCB153. We failed to observe a
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marked differences between the effects of the mixture and the effecs of PCB118 or PCB153
alone, even with genes involved in xenobiotic metabolism, where we have observed the stron-
gest modifications of gene expression.
In summary, our results showed that a short-term exposure to PCB118, PCB153, or a mix-
ture of PCB118 and PCB153 enhanced circulating triglyceride levels without affecting glyce-
mia. Interestingly, the strongest effects were produced by the lowest studied dose of PCB. This
phenomenon has already been described for numerous endocrine disruption processes.
Among the studied tissues, we did not observe changes in inflammation-related genes, such as
cytokines or chemokines. The main transcriptional effects were observed in visceral adipose
tissue and the liver. We found a downregulation of lipin1 and glut4 expression in these two tar-
get organs. In adipose tissue, we also showed a downregulation of Agpat2, Slc25a1, and Fasn.
These genes are involved in lipid metabolism and are associated with insulin resistance. In
muscles, we observed an induction of CnR1 and Foxo3 expression. The induction of Foxo3
suggests that PCB may induce mitochondrial dysfunction in muscles. The metabolic side-
effects of PCB may be due to the modulation of CnR1 in the hypothalamus which controls
appetite and regulates AMPK activity [40]. Moreover, we are exposed to various exogenous
compounds, including procancerogens such as PAH and arylamines. Their bioactivation is cat-
alyzed by Cyp1a which induces inflammatory responses [14] and may enhance the metabolic
effects of PCB. Indeed, type 2 diabetes is linked to the low grade inflammation of visceral adi-
pose tissue. While our results suggest that adipocytes are the main target of the metabolic disor-
ders induced by PCB, further studies are required to fully elucidate these mechanisms, e.g., the
link between lipin 1 and Glut4 expression and the redistribution of Glut4 from intracellular
storage sites to the plasma membrane. Moreover, it would be of interest to further characterize
the synergistic effects and epigenetic regulation of a combined PCB118 and PCB153 exposure.
International Gene Abbreviations Used in Tables
Agpat2: 1-acylglycerol-3-phosphate O-acyltransferase 2. Alox5: arachidonate 5-lipoxygenase.
CD28: CD28 antigen. CnR1: cannabinoid receptor 1. Cyp11a1: Cytochrome P450 11a1.
Cyp1a1: cytochrome P450 1a1. Cyp1a2: cytochrome P450 1a2. Cyp2b10: cytochrome P450
2b10. Cyp2b9: cytochrome P450 2b9. Cyp2c54: cytochrome P450 2c54. Cyp2c70: cytochrome
P450 2c70. Decr1: 2,4-dienoyl CoA reductase 1. Elk4: ETS-domain protein (SRF accessory pro-
tein 1). Eno1: enolase 1. Fasn: fatty acid synthase. Fmo3: flavin containing monooxygenase 3.
Foxo3: forkhead box O3. Gata3: GATA binding protein 3. Gck: glucokinase. Glut4: solute car-
rier family 2 (facilitated glucose transporter), member 4. Gpd1: glycerol-3-phosphate dehydro-
genase 1. Gpx3: glutathione peroxidase 3. Gsta1: glutathione S-transferase alpha 1. Gsta2:
glutathione S-transferase alpha 2. Gsto2: glutathione S-transferase omega 2. Gyk: glycerol
kinase. Ifng: interferon gamma. IL1β: interleukin 1 beta. IL2: interleukin 2. IL5: interleukin 5.
IL6: interleukin 6. Lipc: lipase. Lpin1: lipin 1. Lpin2: lipin 2.Mogat2: monoacylglycerol O-acyl-
transferase 2. Pde8b: phosphodiesterase 8B. Pfkfb3: 6-phosphofructo-2-kinase/fructose-
2,6-biphosphatase 3. Pla2g1b: phospholipase A2, group IB. Pnliprp1: pancreatic lipase related
protein 1. PU1: Spi-1 proto-oncogene b. Pygb: brain glycogen phosphorylase. Rgs2: regulator of
G-protein signaling 2. Slc25a1: solute carrier family 25 (mitochondrial carrier; citrate trans-
porter), member 1. Smpd3: sphingomyelin phosphodiesterase 3. Srgn: serglycin. Sult1e1: sulfo-
transferase family 1E. Tank: TRAF family member-associated NFκB activator.
Supporting Information
S1 File. Genes highlighted after DNA cheap analysis. Abbrevations: Liver 118–10: results
obtained in liver after treatment with PCB118 10 μmol/Kg bw. Liver 118–100: results obtained
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in liver after treatment with PCB118 100 μmol/Kg bw. Liver 153–10: results obtained in liver
after treatment with PCB153 10 μmol/Kg bw. Liver 153–100: results obtained in liver after
treatment with PCB153 100 μmol/Kg bw. Liver MIX-10: results obtained in liver after treat-
ment with an equimolar mixture of PCB118 and PCB153 10 μmol/Kg bw. Liver MIX-100:
results obtained in liver after treatment with an equimolar mixture of PCB118 and PCB153
100 μmol/Kg bw. Colon 118–10: results obtained in colon after treatment with PCB118
10 μmol/Kg bw. Colon 118–100: results obtained in colon after treatment with PCB118
100 μmol/Kg bw. Colon 153–10: results obtained in colon after treatment with PCB153
10 μmol/Kg bw. Colon 153–100: results obtained in colon after treatment with PCB153
100 μmol/Kg bw. Colon MIX-10: results obtained in colon after treatment with an equimolar
mixture of PCB118 and PCB153 10 μmol/Kg bw. Colon MIX-100: results obtained in colon
after treatment with an equimolar mixture of PCB118 and PCB153 100 μmol/Kg bw. Adipose
118–10: results obtained in visceral adipose tissue after treatment with PCB118 10 μmol/Kg
bw. Adipose 118–100: results obtained in visceral adipose tissue after treatment with PCB118
100 μmol/Kg bw. Adipose 153–10: results obtained in visceral adipose tissue after treatment
with PCB153 10 μmol/Kg bw. Adipose 153–100: results obtained in visceral adipose tissue after
treatment with PCB153 100 μmol/Kg bw. Adipose MIX-10: results obtained in visceral adipose
tissue after treatment with an equimolar mixture of PCB118 and PCB153 10 μmol/Kg bw. Adi-
pose MIX-100: results obtained in visceral adipose tissue after treatment with an equimolar
mixture of PCB118 and PCB153 100 μmol/Kg bw. Muscle 118–10: results obtained in muscle
after treatment with PCB118 10 μmol/Kg bw. Muscle 118–100: results obtained in muscle after
treatment with PCB118 100 μmol/Kg bw. Muscle 153–10: results obtained in muscle after
treatment with PCB153 10 μmol/Kg bw. Muscle 153–100: results obtained in muscle after
treatment with PCB153 100 μmol/Kg bw. Muscle MIX-10: results obtained in muscle after
treatment with an equimolar mixture of PCB118 and PCB153 10 μmol/Kg bw. Muscle MIX-
100: results obtained in muscle after treatment with an equimolar mixture of PCB118 and
PCB153 100 μmol/Kg bw.
(XLSX)
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